SELLAS Life Sciences Group, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
SELLAS Life Sciences Group, Inc. (SLS) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$1.40 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2021-11-12
- SELLAS Life Sciences Group, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-09-30 was $1.10M.
- SELLAS Life Sciences Group, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-06-30 was -$2.20M.
- SELLAS Life Sciences Group, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-03-31 was -$300.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month |
|---|---|---|---|
| 2021-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.10M derived: sum of 2 quarters · filed 2021-11-12 | -$1.40M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$2.50M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$300.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |